Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NCChina CDC weekly

Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index — Asia, 1990–2023

  • Yuan Wang1
  • Ning Xu2
  • Jingjing Guo3
  • Yan Yang3
  • Peng Yin4
  • Zhihang Peng5
  • Yang Chen3
  • Hui Shi2
  • Yan Gu3
5 affiliations
  1. 1Clinical Research Center, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China
  2. 2National Health Commission Key Laboratory of Contraceptives Vigilance and Fertility Surveillance, Jiangsu Provincial Medical Key Laboratory of Fertility Protection and Health Technology Assessment, Jiangsu Health Development Research Center, Nanjing City, Jiangsu Province, China
  3. 3Department of Geriatrics, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China
  4. 4National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
  5. 5National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China
Read full textPDFCite

Related

  1. The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies.
    Piyatida Chumnumsiriwath, Stefan O Ciurea, Piyanuch Kongtim
    Current hematologic malignancy reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Risk Factors and Outcomes of Vancomycin-Resistant Enterococcus faecium Bloodstream Infection in Hematologic Malignancies and Stem Cell Transplant Recipients: A Case-Control Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis
    Sohaib Irfan, Harshit Khosla, Saad Nasir +5
    Hematological oncologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Hematologic Malignancies With RUNX1::ZFPM2 Translocation: A Case Report and Literature Review
    Marie Temple, Romain Vazquez, Estelle Balducci +13
    EJHaemPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. 454 Second primary hematologic malignancies in melanoma survivors before and after the introduction of immune checkpoint inhibitors: a population-based SEER analysis
    Jeffrey Afrifa-Yamoah, Damilola Ologbe, Duresha Malik +5
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{wang2026global,
  title = {{Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index — Asia, 1990–2023}},
  author = {Yuan Wang and Ning Xu and Jingjing Guo and Yan Yang and Peng Yin and Zhihang Peng and Yang Chen and Hui Shi and Yan Gu},
  journal = {China CDC weekly},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13673280},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index — Asia, 1990–2023
AU  - Yuan Wang
AU  - Ning Xu
AU  - Jingjing Guo
AU  - Yan Yang
AU  - Peng Yin
AU  - Zhihang Peng
AU  - Yang Chen
AU  - Hui Shi
AU  - Yan Gu
PY  - 2026
DA  - 2026/10/09
JO  - China CDC weekly
UR  - https://europepmc.org/article/PMC/PMC13673280
SN  - 2096-7071
ER  -